SEC Form 4 · accession 0001209191-17-057529
COMMVAULT SYSTEMS INC · CVLT
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
N Robert Hammer
Officer — Chairman, President & CEO · Director
Period of report
Oct 16, 2016
Accepted (ET)
Oct 19, 2017 · 7:23 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001169561
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Oct 16, 2016 | A | 27,800 | $0.00 | A | 2,591,402 | D | |
| Common StockF1 | May 13, 2017 | A | 31,601 | $0.00 | A | 2,602,465 | D | |
| Common StockF2,F3 | May 23, 2017 | A | 27,294 | — | A | 2,609,110 | D | |
| Common StockF1 | Aug 13, 2017 | A | 4,354 | $0.00 | A | 2,611,471 | D | |
| Common StockF1 | Oct 15, 2017 | A | 27,244 | $0.00 | A | 2,634,950 | D | |
| Common StockF4,F5 | Oct 17, 2017 | F | 14,784 | $59.23 | D | 2,620,166 | D | |
| Common StockF1 | Oct 17, 2017 | F | 1 | $60.26 | D | 2,620,165 | D | |
| Common StockF4,F6 | Oct 18, 2017 | F | 1,191 | $59.34 | D | 2,618,974 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1These shares represent vesting of previously granted performance share units.
- F2The common stock is being granted as restricted stock units and is subject to a 3-year vesting schedule, as follows: 1/3 on the first anniversary of the grant with the remaining portion vesting in equal quarterly installments thereafter.
- F3Not applicable.
- F4This sale of common stock was made to satisfy certain tax withholding obligations resulting from the vesting of restricted stock units.
- F5The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $59.20 to $59.90 inclusive.
- F6The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $59.15 to $59.96 inclusive.